371 related articles for article (PubMed ID: 9645764)
1. The membrane-type-matrix metalloproteinase/matrix metalloproteinase-2/tissue inhibitor of metalloproteinase-2 system in periprosthetic connective-tissue remodeling in loose total-hip prostheses.
Takagi M; Santavirta S; Ida H; Ishii M; Akimoto K; Saotome K; Konttinen YT
Lab Invest; 1998 Jun; 78(6):735-42. PubMed ID: 9645764
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema.
Ohnishi K; Takagi M; Kurokawa Y; Satomi S; Konttinen YT
Lab Invest; 1998 Sep; 78(9):1077-87. PubMed ID: 9759652
[TBL] [Abstract][Full Text] [Related]
3. Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements.
Yokohama Y; Matsumoto T; Hirakawa M; Kuroki Y; Fujimoto N; Imai K; Okada Y
Lab Invest; 1995 Dec; 73(6):899-911. PubMed ID: 8558853
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in loose artificial hip joints.
Takagi M; Santavirta S; Ida H; Ishii M; Mandelin J; Konttinen YT
Clin Orthop Relat Res; 1998 Jul; (352):35-45. PubMed ID: 9678031
[TBL] [Abstract][Full Text] [Related]
5. Expression of gelatinase A and its activator MT1-MMP in the inflammatory periprosthetic response to polyethylene.
Nawrocki B; Polette M; Burlet H; Birembaut P; Adnet JJ
J Bone Miner Res; 1999 Feb; 14(2):288-94. PubMed ID: 9933484
[TBL] [Abstract][Full Text] [Related]
6. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer.
Kanayama H; Yokota K; Kurokawa Y; Murakami Y; Nishitani M; Kagawa S
Cancer; 1998 Apr; 82(7):1359-66. PubMed ID: 9529029
[TBL] [Abstract][Full Text] [Related]
7. Tissue inhibitor of metalloproteinase 1, collagenolytic and gelatinolytic activity in loose hip endoprostheses.
Takagi M; Konttinen YT; Kemppinen P; Sorsa T; Tschesche H; Bläser J; Suda A; Santavirta S
J Rheumatol; 1995 Dec; 22(12):2285-90. PubMed ID: 8835563
[TBL] [Abstract][Full Text] [Related]
8. Progesterone differentially regulates the membrane-type matrix metalloproteinase-1 (MT1 -MMP) compartment of proMMP-2 activation in MG-63 cells.
Luo XH; Liao EY
Horm Metab Res; 2001 Jul; 33(7):383-8. PubMed ID: 11507673
[TBL] [Abstract][Full Text] [Related]
9. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
10. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus).
Uekita T; Yamanouchi K; Sato H; Tojo H; Seiki M; Tachi C
Placenta; 2004 Nov; 25(10):810-9. PubMed ID: 15451196
[TBL] [Abstract][Full Text] [Related]
11. Neutral proteinases and their inhibitors in the loosening of total hip prostheses.
Takagi M
Acta Orthop Scand Suppl; 1996 Oct; 271():3-29. PubMed ID: 8975533
[TBL] [Abstract][Full Text] [Related]
12. Gelatinolytic and collagenolytic activity in periprosthetic tissues from loose hip endoprostheses.
Syggelos SA; Eleftheriou SC; Giannopoulou E; Panagiotopoulos E; Aletras AJ
J Rheumatol; 2001 Jun; 28(6):1319-29. PubMed ID: 11409126
[TBL] [Abstract][Full Text] [Related]
13. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
[TBL] [Abstract][Full Text] [Related]
14. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
Jo Y; Yeon J; Kim HJ; Lee ST
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
[TBL] [Abstract][Full Text] [Related]
15. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
[TBL] [Abstract][Full Text] [Related]
16. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2.
Kayano K; Shimada T; Shinomiya T; Nakai S; Hisa Y; Aoki T; Seiki M; Okada Y
J Pathol; 2004 Apr; 202(4):403-11. PubMed ID: 15095267
[TBL] [Abstract][Full Text] [Related]
17. Membrane type 1-matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin.
Jo M; Thomas LE; Wheeler SE; Curry TE
Biol Reprod; 2004 Apr; 70(4):1024-32. PubMed ID: 14668206
[TBL] [Abstract][Full Text] [Related]
18. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
19. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts.
Ottino P; He J; Axelrad TW; Bazan HE
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):487-96. PubMed ID: 15671273
[TBL] [Abstract][Full Text] [Related]
20. High-turnover periprosthetic bone remodeling and immature bone formation around loose cemented total hip joints.
Takagi M; Santavirta S; Ida H; Ishii M; Takei I; Niissalo S; Ogino T; Konttinen YT
J Bone Miner Res; 2001 Jan; 16(1):79-88. PubMed ID: 11149493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
